Inscopix believes that uncovering causal neural circuit dynamics is the key to truly understanding the brain.
Inscopix recognize that current challenges in studying brain function and dysfunction are handicapped by the inability to monitor large groups of neurons at single-cell resolution. Inscopix understands the need to acquire large-scale neural circuit activity data in naturally behaving subjects. With their flagship miniaturized microscope system, nVista HD, Inscopix is enabling you to gather unprecedented data sets in any brain area in awake behaving subjects, to make breakthrough scientific discoveries.
Our vision for bioelectronic medicines is one of miniature, implantable devices that can be attached to individual peripheral nerves anywhere in the viscera.
Such devices would be able to decipher and modulate neural signalling patterns, bringing about therapeutic effects targeted at single functions of specific organs. GSK operates an exploratory research funding program; we have established a $50 million venture arm dedicated to technology and early bioelectronic treatment manifestations and an innovation challenge focussed on rapidly bringing visceral nerve research platforms to the community.
Google engineers are building tools and developing infrastructure to analyze petabytescale datasets generated by the BRAIN Initiative.
Google is working closely with the Allen Institute to develop scalable computational solutions to advance scientific understanding of the brain and with Janelia Research and several academic partners. Google is building the software tools and supporting infrastructure needed to analyze the datasets generated by the BRAIN Initiative to better understand the brain’s computational circuitry and the neural basis for human cognition.
GE has launched a new Brain Health Initiative linking numerous entities within the company such as GE Healthcare, GE Ventures & Healthymagination, and GE’s Global Research Center.
The Initiative will build on and coordinate multiple efforts within the company, including corporate venture capital, open innovation, R&D, and health care lines of business. This includes previously announced efforts at GE, such as the work that the company has done to convene the traumatic brain injury community and support for “Brain Trust” meetings of thought leaders.
Leaders of the National Photonics Initiative (NPI), an alliance of top scientific societies uniting industry and academia to raise awareness of photonics, launched its Photonics Industry Neuroscience Group at the White House BRAIN Initiative launch conference.
Members of the NPI industry group are committing to invest upwards of $30 million in existing and future research and development spending over the next three years to advance optics and photonics technology in support of the White House BRAIN Initiative.
University of California, Berkeley and Carl Zeiss Microscopy are investing $12 million to create the Berkeley Brain Microscopy Innovation Center (BrainMIC).
The BrainMIC will fast-track microscopy development for emerging neurotechnologies and will run an annual course to teach researchers how to use the new technologies. The UC Berkeley Helen Wills Neuroscience Institute is creating a program that will generate innovative devices and analytic tools in engineering, computation, chemistry, and molecular biology to enable transformative brain science from studies of human cognition to neural circuits in model organisms.